NCT05949086Completed
An Online Evaluation of Work Chat
An Online Evaluation of Work Chat: A Virtual Workday Among Employed Autistic Adults
Source: ClinicalTrials.gov · Last updated 8 Dec 2025
Brief summary (registry, in English)
This study is aiming to see if it is feasible for the intervention Work Chat to be delivered in a completely online setting to adults with autism spectrum disorder.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 234 (actual)
- First submitted
- 7 Jul 2023
- Start date
- 7 Jul 2023
- Primary completion date
- 25 Jul 2025
- Lead sponsor
- University of Michigan
- Diseases
- Autism
- NCT number
- NCT05949086
What you commit to
- Study type: Interventional
- Participants enrolled: 234
- From 7 Jul 2023 to the primary completion date, 25 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- Autism Spectrum Disorder
- 18 years or older
- Has 4th grade or higher reading level
- Employed or Unemployed and searching for employment within the next 3 months
- Has access to a computer, laptop, or tablet that has connection to the internet and a camera (not including smartphone)
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Michigan Coordinator of this site? Confirm its status | Ann Arbor | United States | Unknown status |
Related publications
- "I Try to Act Like a Neurotypical so it Makes Customers More Comfortable": A Mixed Methods Analysis of Autistic Camouflaging at Work.J Autism Dev Disord · 2026 · PMID 42545632
This page is information, not medical advice. Discuss any trial with your doctor.